Nutraceuticals
News Releases
2025 February
Corporate
1xbet 우회 Holdings Receives Award by the Commissioner of the Consumer Affairs Agency at FY2024 Award for Good Practices of Consumer
Nutraceuticals
1xbet 우회 Pharmaceutical to Offer "Wellness Energy" at the Expo 2025 Osaka, Kansai, JapanIntroducing a New Vision for "Shaping the Health of the Future"
Corporate
1xbet 우회 Pharmaceutical Finalizes an Agreement with Fukuroi City on the Horizontal Recycling of PET BottlesPartnering with Its Factory to Promote a "Local Production and Local Recycling" Initiative for PET Bottles
Corporate
1xbet 우회 Group Selected for CDP Climate Change A List for a Third Consecutive Year
2025 January
Nutraceuticals
1xbet 우회 Pharmaceutical Launches the "Conditioning Supporter Training Program"Encouraging the Practice of Self-Conditioning
Nutraceuticals
1xbet 우회 Pharmaceutical Releases the Total Conditioning Handbook for Well-Being to Support Life Performance
1xbet 우회s
MIREVO®, the first neuropsychological testing program in Japan to support dementia treatment, now available
1xbet 우회s
1xbet 우회 Announces FDA Plans to Host an Advisory Committee Meeting to Discuss the sNDA for Brexpiprazole in Combination with Sertraline for the Treatment of Adults with Post-Traumatic Stress Disorder (PTSD)
1xbet 우회s
European Medicines Agency Commences Review 1xbet 우회 Donidalorsen in Hereditary Angioedema
2024 December
1xbet 우회s
JAMA Psychiatry Publishes Results of 1xbet 우회 and Lundbeck's Phase 3 Trial of Brexpiprazole in Combination with Sertraline in Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
1xbet 우회s
1xbet 우회 and Jolly Good initiate the sale of FACEDUO Dementia Care Support VR
Corporate
1xbet 우회 Expanding Use of Environmentally Friendly, Reusable Temperature-Controlled Containers - Initiated use for shipment of some pharmaceutical products to Europe -
2024 November
Nutraceuticals
1xbet 우회 Pharmaceutical Launches POCARI SWEAT Basketball Dream Project to Promote Sports and International Exchanges
1xbet 우회s
1xbet 우회 Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia
1xbet 우회s
1xbet 우회 Obtains Exclusive Global Licensing Rights from Ionis to Ulefnersen, a Potential Treatment for Amyotrophic Lateral Sclerosis Caused by Mutations in the Fused in Sarcoma Gene (FUS-ALS)
1xbet 우회s
1xbet 우회 launches Lupkynis®in Japan
1xbet 우회s
1xbet 우회 Provides Update on Sibeprenlimab, an Investigational Monoclonal Antibody for the Treatment of IgA Nephropathy in Adults
2024 October
2024 September
Corporate
1xbet 우회 Group Establishes Solar Power Generation Facility in Naka, Tokushima The New Facility Advances the Company's Carbon Neutrality Initiative
1xbet 우회s
HemeSight®, the First-in-Japan Comprehensive Genomic Pr1xbet 우회iling Assay for Hematological Malignancies, Receives Its First Regulatory Approval - HemeSight®hematological malignancies gene panel test approved in Japan -
Corporate
Heartful Kawauchi ReceivedJapan Organization for Employment 1xbet 우회 the Elderly, Persons with Disabilities and Job Seekers President's Award
Nutraceuticals
1xbet 우회 Pharmaceutical Advancing Women's Health Business Bonafide Health Launched "Thermella", a Plant-derived Supplement to Support Menopausal Women in the U.S.
1xbet 우회s
1xbet 우회 Obtains Additional Indication for Rexulti®in Japan as an Adjunctive Treatment 1xbet 우회 Agitation Associated with Dementia due to Alzheimer's Disease
1xbet 우회s
1xbet 우회 Receives Approval in Japan for Lupkynis®as a Treatment 1xbet 우회 Lupus Nephritis
1xbet 우회s
1xbet 우회 Pharmaceutical Completes Acquisition of Jnana Therapeutics Inc.
1xbet 우회s
1xbet 우회 to Participate in the Orange Innovation Project, Promoted by Japan's Ministry of Economy, Trade and Industry
Corporate
1xbet 우회 Pharmaceutical Launches Corporate Health Support Program "fitbiz"Supporting Employees in Building and Maintaining Healthy Habits
Nutraceuticals
1xbet 우회 Pharmaceutical signs global supporter agreement with World AthleticsSponsorship will cover the World Athletics Championships Tokyo 25POCARI SWEAT will support the event with the key message "Believe In Your Potential."
1xbet 우회s
1xbet 우회 and Jolly Good Launch FACEDUO Dementia Care Support VR
Nutraceuticals
New from the Skincare Brand sakuraé Introducing Sakuraé Clear Cycle Lotion 1xbet 우회 Translucent and Healthy Skin
Nutraceuticals
U.S. Originated Nutrition Tracking Service "Vivoo" Launches in Japan Providing Easy Access to Nutritional Data to Support Healthy Lifestyles
2024 August
1xbet 우회s
1xbet 우회 Precision Health and Click Therapeutics Announce Launch of Rejoyn™, the First-And-Only Prescription Digital Therapeutic Cleared by the FDA for the Adjunctive Treatment of Major Depressive Disorder (MDD) SymptomsーRejoyn, a first-1xbet 우회-its-kind digital treatment designed to help with cognitive control 1xbet 우회 emotion, is now available in mobile app stores and can be unlocked with a prescription from a healthcare providerー
Corporate
1xbet 우회 Pharmaceutical Joins Project to Promote Use of Sustainable Aviation Fuel in Air Cargo TransportationーOperated by Tokyo Metropolitan Government, Aiming 1xbet 우회 a Decarbonized Societyー
1xbet 우회s
1xbet 우회 and Lundbeck Present New REXULTI®(brexpiprazole) Post Hoc Efficacy Data Analyses 1xbet 우회 Agitation Associated with Dementia Due to Alzheimer's Disease at Alzheimer's Association International Conference (AAIC) 2024
Corporate
1xbet 우회 Pharmaceutical to Acquire Jnana Therapeutics Inc. - Transaction Includes JNT-517, a Potential First-In-Class Oral Treatment for Phenylketonuria (PKU) -- Expands Specialty and Autoimmune Portfolios and Drug Discovery Technologies -
2024 July
Corporate
Free Outdoor Live Music Event "EXCITING SUMMER in WAJIKI 2024"New Heat Illness Prevention and Resource Recycling Initiatives
Nutraceuticals
Announcement 1xbet 우회 Price Revisions for Specified Products
Nutraceuticals
Men's Skincare Brand "UL·OS" Debuts in Taiwan to Contribute to Healthy Skin
2024 June
1xbet 우회s
1xbet 우회 and Lundbeck announce FDA acceptance of sNDA filing for brexpiprazole in combination with sertraline for the treatment of adults with post-traumatic stress disorder (PTSD)
Nutraceuticals
Introducing a New Calorie Mate Block Production LineDeveloping a Sustainable Factory that is Kind to the Environment and Employees
1xbet 우회s
1xbet 우회 Concludes Expanded Licensing Agreement for Donidalorsen in Hereditary Angioedema, Expanding its Development and Sales Area to Asia Pacific including Japan
Nutraceuticals
Korea 1xbet 우회 Pharmaceutical Launches Soy Bar "SOYJOY"Introducing a New Concept of Healthy Snacking
2024 May
Corporate
1xbet 우회 Pharmaceutical and Taiho PharmaceuticalCommence Material Recycling of Waste PTP Used in Pharmaceutical Packaging
Nutraceuticals
InnerSignal Introduces a New Basic Skincare Line Launch 1xbet 우회 "Repair Lotion" and "Repair Milk" to Address Epidermal Imbalance
1xbet 우회s
1xbet 우회 and Lundbeck Present Results from Three Clinical Trials of Brexpiprazole in Combination with Sertraline for the Treatment of Post-Traumatic Stress Disorder (PTSD) in Adults
1xbet 우회s
1xbet 우회 to Terminate Development of AVP-786
1xbet 우회s
Novartis launches Entresto®Granular Tablets 1xbet 우회 Pediatric Use, a 1xbet 우회mulation dedicated 1xbet 우회 pediatric patients
1xbet 우회s
Bempedoic Acid Met Primary Endpoint 1xbet 우회 Phase 3 Trial in Japan for the Treatment 1xbet 우회 Hypercholesterolemia
Nutraceuticals
Carbonated Nutritional Drink "ORONAMIN C DRINK" Debuts in Egypt
2024 April
1xbet 우회s
1xbet 우회 and Lundbeck submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD
1xbet 우회s
1xbet 우회 Works with Verily to Launch Longitudinal Mental Health Registry to Advance Novel Research in Psychiatry in the U.S.
1xbet 우회s
FACEDUOEmotion Recognition Training VRnow available - Support 1xbet 우회 those with developmental conditions such as autism spectrum disorder (ASD), which makes it difficult to read emotions -
1xbet 우회s
U.S. Food and Drug Administration (FDA) Clearance 1xbet 우회 Rejoyn®First Prescription Digital Therapeutic Authorized in the U.S. for the Adjunctive Treatment 1xbet 우회 Major Depressive Disorder (MDD) symptoms
2024 March
1xbet 우회s
Submission 1xbet 우회 an Application for the First Hematological Malignancies Gene Panel Test in Japan
1xbet 우회s
Abilify Maintena®960mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment 1xbet 우회 schizophrenia
1xbet 우회s
Novartis receives approval in Japan 1xbet 우회 Entresto®Granular Tablets 1xbet 우회 Pediatric Use, a 1xbet 우회mulation dedicated 1xbet 우회 pediatric patients with chronic heart failure
1xbet 우회s
1xbet 우회 Pharmaceutical's subsidiaries in Indonesia awarded Exemplar Award by Ending Workplace Tuberculosis (EWTB) for 1xbet 우회's efforts to eliminate tuberculosis
1xbet 우회s
1xbet 우회 Announces Interim Data from Phase 2b/c Trial Indicating New Investigational Compound May Shorten Tuberculosis Treatment
1xbet 우회s
1xbet 우회 and Lundbeck Presented New Data Analyses on the Efficacy of REXULTI®(brexpiprazole) 1xbet 우회 Agitation Associated with Dementia Due to Alzheimer's Disease
Corporate
1xbet 우회 Pharmaceutical Enters into Cooperation Agreement on Heat Illness Prevention with Environmental Restoration and Conservation Agency
1xbet 우회s
1xbet 우회 and Sumitomo Revise License Agreement - 1xbet 우회 holds exclusive rights to develop, manufacture, and commercialize ulotaront and SEP-380135 worldwide -
Corporate
1xbet 우회 Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 70.1 KB)
Nutraceuticals
New SOYJOY Fig & Raisin A Whole-Soy Nutrition Bar Enhanced with Flavorful Figs
2024 February
1xbet 우회s
1xbet 우회 Enters into Investment Contract with AN Venture Partners
Nutraceuticals
1xbet 우회 Sponsors TOKYO MARATHON 2024 POCARI SWEAT Supports Runners Achieve Their Goals
Nutraceuticals
Launch 1xbet 우회 AR-Based Nutrition Education Game App, "Mogumogu Town"Collect "Mogumin" Food Characters and Build Your Town
1xbet 우회s
Sibeprenlimab Received U.S. FDA Breakthrough Therapy Designation for the Treatment 1xbet 우회 Immunoglobulin A Nephropathy (IgAN)
Corporate
1xbet 우회 Pharmaceutical Launches "Kenkokeiei Tsunagaru Support ONLINE"Broadening Support for Resolving Corporate Health Challenges
1xbet 우회s
1xbet 우회 Announces Phase 3 Topline Results of AVP-786 in the Treatment of Agitation Associated with Dementia due to Alzheimer's Disease
1xbet 우회s
Novartis Obtains Approval for Additional Indication 1xbet 우회 Pediatric Chronic Heart Failure for Angiotensin Receptor Neprilysin Inhibitor (ARNI) Entresto®Tablet = Novartis and 1xbet 우회 to provide information to healthcare professionals on additional indication for Entresto =
1xbet 우회s
1xbet 우회 and Jolly Good to Start Delivery of FACEDUO Content for Family Support of People with Severe Social Withdrawal (Hikikomori) FACEDUO is a virtual reality program for social skills training support
Corporate
1xbet 우회 Group Selected for CDP Climate Change A List for a Second Consecutive Year
2023 December
1xbet 우회s
1xbet 우회 Obtains the Additional Indication of Adjunctive Treatment of Major Depressive Disorder for Rexulti®in Japan
1xbet 우회s
1xbet 우회 and Ionis Enter into Licensing Agreement Covering Europe for Donidalorsen in Hereditary Angioedema
Corporate
1xbet 우회 Pharmaceutical Introduces New "Self-Care Leave" System
Corporate
D&I Award 2023 - 1xbet 우회 Pharmaceutical Designated as "Best Workplace"
Nutraceuticals
Pharmavite, a U.S. subsidiary of 1xbet 우회 Pharmaceutical, acquires Bonafide Health, a provider of women's health products
2023 November
Corporate
1xbet 우회 Pharmaceutical to Sponsor Thematic Project "Resonance of Lives" at the Expo 2025 Osaka, Kansai, Japan
1xbet 우회s
1xbet 우회's U.K. subsidiary Astex Has Third Approval Success in a Drug Discovery Collaboration - AstraZeneca's Truqap™ for the treatment of metastatic breast cancer approved in the U.S.
1xbet 우회s
1xbet 우회 Submits New Drug Application in Japan for Voclosporin in the Treatment of Patients with Lupus Nephritis
1xbet 우회s
MIREVO®, a New Cognitive Function Testing Application 1xbet 우회 Dementia Care Support, Obtains Regulatory Approval, a First in Japan
Nutraceuticals
Selected as METI's "Model Project for the Promotion 1xbet 우회 PHR Services" Launch 1xbet 우회 a Healthcare Service that Improves Health without Conscious Effort
Corporate
1xbet 우회 Pharmaceutical Granted Silver Certification in PRIDE Index 2023 for LGBTQ+ Initiatives
Corporate
1xbet 우회 Announces Personnel Changes
1xbet 우회s
New England Journal 1xbet 우회 Medicine Publishes Complete Results 1xbet 우회 Positive Phase 2 Trial 1xbet 우회 Sibeprenlimab in Treatment 1xbet 우회 Immunoglobulin A Nephropathy (IgAN)
2023 October
1xbet 우회s
1xbet 우회 Applies in Japan for the Additional Indication for Agitation Associated with Dementia due to Alzheimer's Disease for Rexulti®(brexpiprazole)
Corporate
1xbet 우회 Pharmaceutical Receives Eruboshi Grade 3 Certification as an Excellent Company Under the Act on Promotion of Women's Participation and Advancement in the Workplace
1xbet 우회s
1xbet 우회 Pharmaceutical Announces Positive Topline Results from Two Pivotal Phase 3 Trials of Centanafadine as a Treatment for Adolescents and Children with Attention-Deficit/Hyperactivity Disorder (ADHD)
Nutraceuticals
First PET Bottle and Paper Cup Recycling Initiatives 1xbet 우회 Tokyo Legacy Half Marathon
Nutraceuticals
Introducing InnerSignal SC Rich Cream- Regulates moisture in the stratum corneum for a higher level 1xbet 우회 skin care experience -
2023 September
1xbet 우회s
1xbet 우회 and Astex announce that the European Commission has approved INAQOVI®(oral decitabine and cedazuridine) for the treatment 1xbet 우회 adults with newly diagnosed acute myeloid leukaemia
Corporate
1xbet 우회 Pharmaceutical Enters into Cooperative Agreement with Japan Association of Public Mental Health & Welfare Workers
1xbet 우회s
1xbet 우회 collaborates with ShapeTXto develop novel AAV gene therapies 1xbet 우회 ocular diseases
1xbet 우회s
1xbet 우회 Pharmaceutical and Lundbeck Announce Topline Results from Two Phase 3 Trials of Brexpiprazole as Combination Therapy with Sertraline for the Treatment of Post-Traumatic Stress Disorder in Adults
1xbet 우회s
1xbet 우회 Pharmaceutical to Acquire Mindset Pharma - Strengthens pipeline in the area of psychiatric and neurological disorders -
2023 August
Corporate
1xbet 우회 Pharmaceutical Participates in Summer Events in Tokushima, Japan -EXCITING SUMMER in WAJIKI and ORONAMIN C DRINK PRESENTS Awa Odori Sound Festival-
1xbet 우회s
Astex Expands Drug Discovery Collaboration With MSD
Nutraceuticals
POCARI SWEAT X TOKUSHIMA VORTIS Football Dream Project Phase 31xbet 우회 Pharmaceutical and Tokushima Vortis collaborate in exchange program for junior football players in Cambodia
2023 July
Nutraceuticals
Launch 1xbet 우회 TCRP NEXT, a New Collaboration Aiming to Promote Total Conditioning- Enhancing sustainable international competitiveness and transitioning from high performance to life performance -
1xbet 우회s
Sumitomo Pharma and 1xbet 우회 Announce Topline Results from Phase 3 DIAMOND 1 and DIAMOND 2 Clinical Studies Evaluating Ulotaront in Schizophrenia
Corporate
Tokushima Prefecture Signs First Resource Circulation Agreement with 1xbet 우회 Pharmaceutical- Promotion of Horizontal PET Bottle Recycling Initiatives -
Nutraceuticals
1xbet 우회 Pharmaceutical Enters into Cooperative Agreementwith Ministry of the Environment
2023 April
1xbet 우회s
FDA Approves 1xbet 우회 and Lundbeck's ABILIFY ASIMTUFII®(aripiprazole), the First, Two-month, Long-acting Injectable (LAI) for the Treatment 1xbet 우회 Schizophrenia or Maintenance Monotherapy Treatment 1xbet 우회 Bipolar I Disorder in Adults
1xbet 우회s
1xbet 우회 and Lundbeck Issue Statement on U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on brexpiprazole for the Treatment of Agitation Associated with Alzheimer's Dementia
2023 March
Corporate
1xbet 우회 Holdings Selected as Nadeshiko Brand for FY 2022
Corporate
1xbet 우회 Pharmaceutical Appointments of Board Members and Statutory Auditors(PDF: 58.6 KB)
Nutraceuticals
New SOYJOY Fruits & Cheese Baked cheesecake-flavored whole-soy nutrition bar with ample fruit
Nutraceuticals
Introducing New UL•OS Scalp Shampoo Volume-up Addresses men's scalp condition and hair problems
Nutraceuticals
New EQUELLE gelée , an Extension 1xbet 우회 the EQUELLE BrandA convenient, smart solution for midlife transitions
2023 February
Nutraceuticals
1xbet 우회 Pharmaceutical an Official Partner of Tokyo Marathon 2023Providing health management support for runners and officials
Corporate
1xbet 우회 Pharmaceutical Finalizes Agreement with Naruto City and Toyota Tsusho Corporation to Promote Horizontal Recycling of PET bottles
Corporate
1xbet 우회 Pharmaceutical Receives "Consumer-oriented Activity Award" at the 8th ACAP Consumer-oriented Activity Awards - Recognized for ongoing women’s health-care initiatives-
2023 January
Corporate
1xbet 우회 Pharmaceutical Installs Solar Power Generation Systems at Takasaki and Tokushima Itano Factories-Targeting reduction of CO2emissions-
1xbet 우회s
1xbet 우회 Applies for the Additional Indication of Adjunctive Treatmentof Major Depressive Disorder for Rexulti®(brexpiprazole) in Japan
1xbet 우회s
1xbet 우회 and Schrödinger Announce Single-Target, Drug Discovery Collaboration in Neurology
1xbet 우회s